Sawa H, Takeshita I, Kuramitsu M, Mannoji H, Machi T, Fukui M, Kitamura K
Anticancer Res. 1986 Sep-Oct;6(5):905-9.
Neuronal and glial specific proteins were studied in 35 cases of medulloblastomas, using immunohistochemical methods and antibodies to neurofilament triplet proteins (NF68Kd, NF160Kd, NF210Kd), gamma-enolase, GFAP, S-100 protein, and myelin basic protein. NF160Kd positive cells were observed in 12 of the 35 cases. NF160Kd positive cells were noted in 2, but NF210Kd positive cells were not detected. Gamma-enolase positive cells were observed in 23 cases. GFAP and S-100 protein positive cells were seen in 25 and 28 cases respectively; many of these cells were reactive astrocytes. The myelin basic protein positive cells could not be identified. The expression of neuronal and glial proteins had no relation to the postoperative survival of patients with medulloblastoma, but gamma-enolase may be one factor for evaluating prognosis.
采用免疫组化方法,使用针对神经丝三联蛋白(NF68Kd、NF160Kd、NF210Kd)、γ-烯醇化酶、胶质纤维酸性蛋白(GFAP)、S-100蛋白和髓鞘碱性蛋白的抗体,对35例髓母细胞瘤患者的神经元和神经胶质特异性蛋白进行了研究。35例中有12例观察到NF160Kd阳性细胞。有2例发现NF160Kd阳性细胞,但未检测到NF210Kd阳性细胞。23例观察到γ-烯醇化酶阳性细胞。分别在25例和28例中见到GFAP和S-100蛋白阳性细胞;其中许多细胞为反应性星形胶质细胞。未发现髓鞘碱性蛋白阳性细胞。神经元和神经胶质蛋白的表达与髓母细胞瘤患者术后生存率无关,但γ-烯醇化酶可能是评估预后的一个因素。